SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

The last trading session went well for Axxess Pharma Inc (OTCMKTS:AXXE) on account of a brand new development. The company said that it has inked an agreement with ‘Nutrition House’, as per which, it will now be able to extend its Tapeout range of products to more than 60 high-profile shopping centers in Canada. The company will go on shelves by as early as summer.

New shelves in Canada

The company elaborated that the agreement came into reality after Nutrition House evaluated its Tapeout product range. During a careful review, Nutrition House concluded that Axxess Pharma Inc (OTCMKTS:AXXE)’s high potency Omega 3 Fish Oil Supplements as well as all-natural, gluten-free protein shakes will best suit the needs of their health-conscious consumers. At the same time, Nutrition House projects a strong demand for the Tapeout range as it anticipates an increasing number of consumers to become aware of the product available on its shelves.

Strong Year

Axxess Pharma Inc (OTCMKTS:AXXE) will get leverage from Nutrition House’s strong brand presence in Canada, where it is renowned as the provider of high-grade products. Some of the products offered by Nutrition House include supplements, vitamins, body care and other exclusive products. On the other hand, the move indicates Axxess Pharma Inc (OTCMKTS:AXXE)’s efforts to push its products to a growing number of pharmacies, shopping centers, and other offline retail stores. Additionally, the company is firm on its plan to reach out globally through a network of industry leading health distributors.

The company’s President Dr. Bagi further highlighted that it has grown its footprint in Australia, while it has received approval by a renowned Canadian distributor to sell Muscle Spray and Tapeout Pan relief to nearly 2,000 independent pharmacies all over Canada. The company envisions 2015 as a strong growth year. The news pushed the stock of Axxess Pharma Inc (OTCMKTS:AXXE) up by 4.50% to $0.0889 as 1.46 million traded hands.